Elevation of serum gamma-glutamyl transpeptidase in end-stage chronic renal failure - PubMed (original) (raw)
Elevation of serum gamma-glutamyl transpeptidase in end-stage chronic renal failure
A Fine et al. Scott Med J. 1975 May.
Abstract
The serum gamma-glutamyl transpeptidase (GGT) was measured on 32 randomly selected patients about to commence or already on chronic haemodialysis. Raised values were found in 12 patients (37%). None of these patients had received drugs known to affect hepatic microsomes and all had normal liver function tests. The possible significance of this surprising finding is discussed.
Similar articles
- Serum gamma-glutamyl transferase activity in chronic renal failure during regular hemodialysis and after successful renal transplantation.
Pierides AM, Skillen AW. Pierides AM, et al. Clin Chim Acta. 1977 May 16;77(1):83-9. doi: 10.1016/0009-8981(77)90405-3. Clin Chim Acta. 1977. PMID: 17491 - [Study of urinary gamma-glutamyltranspeptidase. (2) Clinical significance of urinary gamma-glutamyl-transpeptidase (author's transl)].
Cho H, Sano K, Hosaki S. Cho H, et al. Rinsho Byori. 1977 Nov;25(11):921-5. Rinsho Byori. 1977. PMID: 24128 Japanese. No abstract available. - The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma.
Sandock DS, Seftel AD, Resnick MI. Sandock DS, et al. J Urol. 1997 Mar;157(3):798-9. J Urol. 1997. PMID: 9072569 - Gamma-glutamyltransferase activity in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection.
Souza JF, Longui CA, Miorin LA, Sens YA. Souza JF, et al. Transplant Proc. 2008 Jun;40(5):1319-23. doi: 10.1016/j.transproceed.2008.03.157. Transplant Proc. 2008. PMID: 18589096 - Serum gamma-glutamyl transpeptidase: a prognostic marker in cardiovascular diseases.
Emdin M, Passino C, Pompella A, Paolicchi A. Emdin M, et al. Biofactors. 2003;17(1-4):199-205. doi: 10.1002/biof.5520170119. Biofactors. 2003. PMID: 12897441 Review. No abstract available.
Cited by
- Glyphosate's Synergistic Toxicity in Combination with Other Factors as a Cause of Chronic Kidney Disease of Unknown Origin.
Gunatilake S, Seneff S, Orlando L. Gunatilake S, et al. Int J Environ Res Public Health. 2019 Jul 31;16(15):2734. doi: 10.3390/ijerph16152734. Int J Environ Res Public Health. 2019. PMID: 31370256 Free PMC article. Review. - The Role of Glutathione Metabolism in Chronic Illness Development and Its Potential Use as a Novel Therapeutic Target.
Hristov BD. Hristov BD. Cureus. 2022 Sep 28;14(9):e29696. doi: 10.7759/cureus.29696. eCollection 2022 Sep. Cureus. 2022. PMID: 36321012 Free PMC article. Review. - Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review.
Sette LH, Almeida Lopes EP. Sette LH, et al. Clinics (Sao Paulo). 2014;69(4):271-8. doi: 10.6061/clinics/2014(04)09. Clinics (Sao Paulo). 2014. PMID: 24714836 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous